Abstract: The present disclosure provides an immersion vaccine for fish comprising at least one isolated antigen, specifically a recombinant antigen, such as is F. psychrophilum and/or infectious pancreatic necrosis virus (IPNV).
Type:
Grant
Filed:
April 17, 2017
Date of Patent:
May 19, 2020
Assignee:
BENCHMARK ANIMAL HEALTH LIMITED
Inventors:
Elizabeth Mary Crump, Jan Burian, Joseph Michale Bricker, William Wayne Kay, Norman William Johnson
Abstract: Methods of producing, propagating and multiplying viruses, methods of identifying the presence of a virus in a sample, specifically methods using Japanese eel cell cultures. Also provided are an isolated Japanese eel cell culture, optionally infected with a virus, vaccines comprising viruses grown according to the methods of the invention, and a kit for propagating viruses comprising the Japanese eel cell culture. The virus may be a fish virus such as nodavirus, Infectious Pancreatic Necrosis Virus (IPNV) and Salmon Pancreas Disease Virus (SPDV).
Abstract: The present disclosure relates to treatment of chitin-containing microorganism infection or colonization on an aquatic animal. The methods, systems, and kits provided herein facilitate termination and/or inhibition of proliferation of chitin-containing microorganisms (e.g., Saprolegnia and sea lice).
Type:
Grant
Filed:
December 17, 2014
Date of Patent:
October 31, 2017
Assignee:
BENCHMARK ANIMAL HEALTH LIMITED
Inventors:
Shimaa E. Ali, Even Thoen, Ida Skaar, Øystein Evensen